<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04989530</url>
  </required_header>
  <id_info>
    <org_study_id>E-94603339-604.01.02-46403</org_study_id>
    <nct_id>NCT04989530</nct_id>
  </id_info>
  <brief_title>Comparison of Ultrasonographic and Clinical Features of Different Energy Levels Extracorporeal Shock Wave Therapy in Plantar Fasciitis</brief_title>
  <official_title>Comparison of Ultrasonographic and Clinical Features of Different Energy Levels Extracorporeal Shock Wave Therapy in Plantar Fasciitis: A Randomized, Prospective, Double-blind Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Baskent University Ankara Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Baskent University Ankara Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Plantar fasciitis is the most common cause of heel pain in adults. It received FDA approval&#xD;
      in 2000 for ESWT in the treatment of plantar fasciitis in adults whose pain did not resolve&#xD;
      with conservative treatment.&#xD;
&#xD;
      ESWT energy levels are categorized as high, medium and low. It is not yet clear which energy&#xD;
      level is most effective in the clinical recovery and pain relief of plantar fasciitis after&#xD;
      ESWT treatment. Although there are studies in the literature evaluating the effect of&#xD;
      different energy densities in the treatment of plantar fasciitis with ESWT, there are very&#xD;
      few studies comparing different treatment doses of ESWT.&#xD;
&#xD;
      The aim of this study was to evaluate and compare the therapeutic effects of low, medium and&#xD;
      high energy ESWT in patients with plantar fasciitis, and also to examine the correlation&#xD;
      between plantar fascia thickness changes ultrasonographically and clinical outcomes.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 1, 2021</start_date>
  <completion_date type="Anticipated">September 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">September 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Foot Function index</measure>
    <time_frame>1 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Plantar fasia thickness</measure>
    <time_frame>1 months</time_frame>
    <description>Measurement of plantar fascia thickness with ultrasound</description>
  </secondary_outcome>
  <other_outcome>
    <measure>visual analogue scale</measure>
    <time_frame>1 months</time_frame>
  </other_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">78</enrollment>
  <condition>Extracorporeal Shock Wave Therapy</condition>
  <arm_group>
    <arm_group_label>Low energy level of ESWT</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>medium energy level of ESWT</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>high energy level of ESWT</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Extracorporeal Shock Wave Therapy</intervention_name>
    <description>different energy levels of ESWT</description>
    <arm_group_label>Low energy level of ESWT</arm_group_label>
    <arm_group_label>high energy level of ESWT</arm_group_label>
    <arm_group_label>medium energy level of ESWT</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        presence of heel pain, tenderness at the insertion site of the plantar fascia on the&#xD;
        anteromedial aspect of the calcaneal tubercle elicited by palpation, and unresponsiveness&#xD;
        to medical treatment.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        history of inflammatory rheumatic disease, trauma of the foot or foot surgery, local&#xD;
        dermatological lesion or infection, impaired peripheral circulation, a neurological&#xD;
        disorder such as radiculopathy and neuropathy, patients with sequelae of lower extremity&#xD;
        fracture, a congenital or acquired deformity, malignancy, cardiac pacemaker, metal implant&#xD;
        at the application site, pregnancy, anticoagulant use for coagulopathy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Baskent University Ankara Hospital</name>
      <address>
        <city>Ankara</city>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Şükran Güzel</last_name>
      <phone>+903122036868</phone>
      <email>sukranguzel@windowslive.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>July 26, 2021</study_first_submitted>
  <study_first_submitted_qc>July 26, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 4, 2021</study_first_posted>
  <last_update_submitted>July 26, 2021</last_update_submitted>
  <last_update_submitted_qc>July 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 4, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Baskent University Ankara Hospital</investigator_affiliation>
    <investigator_full_name>Şükran Güzel</investigator_full_name>
    <investigator_title>M.D.</investigator_title>
  </responsible_party>
  <keyword>Extracorporeal Shock Wave Therapy</keyword>
  <keyword>ultrasonography</keyword>
  <keyword>plantar fasiit</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fasciitis</mesh_term>
    <mesh_term>Fasciitis, Plantar</mesh_term>
    <mesh_term>Shock</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

